tirzepatide phase 3 study results Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, trial TrimRX | Tirzepatide Results Timeline:

Our mission is to make these clinical tools accessible and easy to manage from the comfort of your home

Customizable for Compounding Pharmacies Ideal for oral, topical, or injectable prescription formulations (compounding pharmacy, custom medication, prescription ingredients)

Perlmutter brings an expert perspective to the Levels team to support product features, research, and education related to neurologic health, behavior change, and behavioral psychology

Lazarus Labs supplies it in Australia as a 10 mg lyophilised reference material (5 mg + 5 mg) at 99 % purity, with a certificate of analysis for every lot

Jan M Krzak, MD 2